STEPHEN BOLIVAR: Open Payments
NPI 1598199291 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 10 payments from 6 companies in 2025. Trend: 2023 $29 · 2024 $0 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $74 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $44 |
| Lilly USA, LLC | 1 | $30 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Korlym, JARDIANCE, Ozempic, RECORLEV, GVOKE HYPOPEN, NP Thyroid 60.
Industry payments across MS — which companies pay providers there.
